Pharma
Yatharth Hospital & Trauma Care Services Ltd
YATHARTH · NSE · INE0JO301016Monday, 26 Oct 20262:46 pm
Market Cap₹8,991 Cr
P/E49.6
P/B5.1
EPS₹18.8
Div Yield0.1%
ROE10.0%
ROCE10.8%
ROE10.0%
1Y Return+64.42%
Avg. Volume0.4M
Price Chart
52-Week Range
About
Yatharth Hospital & Trauma Care Services Ltd is a Pharma company listed on NSE.
Technicals
Free account
Register freeTechnicals
Create a free account to view momentum, moving averages, and delivery signals.
Quant
Premium
UpgradeQuant metrics
Upgrade to view volatility, drawdown, factor, and risk metrics.
Key Ratios
Market Cap₹8,991 Cr
Current Price₹933.1
52W High / Low₹1,184 / ₹538.25
Stock P/E49.6
Price to Book5.1
EPS (TTM)₹18.8
Dividend Yield0.1%
ROE10.0%
1Y Return+64.42%
Day Change+0.14%
Profit & Loss
| Period | TTM | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹1,334 Cr | ₹1,207 Cr | ₹886 Cr | ||||||||
| Expenses | ₹1,024 Cr | ₹902 Cr | ₹655 Cr | ||||||||
| Operating Profit | ₹310 Cr | ₹305 Cr | ₹230 Cr | ||||||||
| OPM % | 23.0% | 25.0% | 26.0% | ||||||||
| Other Income | ₹29 Cr | ₹25 Cr | ₹11 Cr | ||||||||
| Depreciation | ₹101 Cr | ₹88 Cr | ₹57 Cr | ||||||||
| Interest | ₹13 Cr | ₹19 Cr | ₹12 Cr | ||||||||
| Profit Before Tax | ₹225 Cr | ₹224 Cr | ₹172 Cr | ||||||||
| Tax | ₹51 Cr | ₹54 Cr | ₹41 Cr | ||||||||
| Net Profit | ₹174 Cr | ₹170 Cr | ₹131 Cr | ||||||||
| EPS (₹) | 18.8 | 18.2 | 13.6 | ||||||||
| Dividend Payout % | — | 0% | 0% |
Financial history locked
Register freeRegister free to see 8 more years.
Quarterly Results
| Quarter | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹393 Cr | ₹342 Cr | ₹320 Cr | ₹279 Cr | |||||||||
| Expenses | ₹301 Cr | ₹262 Cr | ₹246 Cr | ₹215 Cr | |||||||||
| Operating Profit | ₹92 Cr | ₹80 Cr | ₹74 Cr | ₹65 Cr | |||||||||
| OPM % | 23.0% | 23.0% | 23.0% | 23.0% | |||||||||
| Depreciation | ₹28 Cr | ₹30 Cr | ₹24 Cr | ₹19 Cr | |||||||||
| Interest | ₹7 Cr | ₹5 Cr | ₹1 Cr | ₹0 Cr | |||||||||
| Net Profit | ₹45 Cr | ₹45 Cr | ₹43 Cr | ₹41 Cr | |||||||||
| EPS (₹) | 4.9 | 4.9 | 4.7 | 4.3 |
Quarterly history locked
Register freeRegister free to see 9 more quarters.
Balance Sheet
| Period | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Capital | ₹96 Cr | ₹96 Cr | ₹86 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reserves | ₹1,684 Cr | ₹1,509 Cr | ₹788 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Borrowings | ₹264 Cr | ₹12 Cr | ₹85 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Liabilities | ₹218 Cr | ₹114 Cr | ₹60 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ₹2,262 Cr | ₹1,731 Cr | ₹1,019 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Assets | ₹1,250 Cr | ₹605 Cr | ₹442 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | ₹2 Cr | ₹74 Cr | ₹0 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Equivalents | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets | ₹909 Cr | ₹829 Cr | ₹577 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Assets | ₹2,262 Cr | ₹1,731 Cr | ₹1,019 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance sheet history locked
Register freeRegister free to see 8 more years.
Cash Flow
| Period | Operating | Investing | Financing | Net Cash Flow |
|---|---|---|---|---|
| FY26 | ₹205 Cr | ₹-598 Cr | ₹254 Cr | ₹-140 Cr |
| FY25 | ₹131 Cr | ₹-388 Cr | ₹509 Cr | ₹253 Cr |
| FY24 | ₹-3 Cr | ₹-226 Cr | ₹304 Cr | ₹75 Cr |
| FY23 | ||||
| FY22 | ||||
| FY21 | ||||
| FY20 | ||||
| FY19 | ||||
| FY18 | ||||
| FY17 |
Cash flow history locked
Register freeRegister free to see 8 more years.
Peer Comparison
| Company | M.Cap | P/E | ROE | 1Y Return |
|---|---|---|---|---|
| 3B BlackBio Dx Ltd | ₹1,210 Cr | 21.4 | +20.2% | +17.9% |
| Aarey Drugs & Pharmaceuticals Ltd | — | — | +2.75% | +59.84% |
| Aarti Drugs Ltd | ₹3,429 Cr | 18.0 | +13.37% | +11.57% |
| Aarti Pharmalabs Ltd | ₹7,495 Cr | 35.2 | +8.51% | +14.26% |
| Abbott India Ltd | — | — | +34.46% | -7.16% |
Mutual Fund Holdings
Free account
Register freeMutual fund holdings
Create a free account to see institutional ownership snapshots.
Bulk & Block Deals
Free account
Register freeBulk & block deals
Create a free account to view recent institutional deal activity.
Analyst Estimates
Free account
Register freeAnalyst estimates
Create a free account to view analyst estimate summaries.
Latest News
2026-09-23Westinghouse Air Brake (WAB) Signs $700 Million-Plus Rail Services Deal. Can Profits Grow?Insider Monkey2026-09-17Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationBSE Filing2026-09-06VITG Unveils Modern Managed Services and Managed Detection & Response as Part of a Broader AI and Cybersecurity Transformation across ANZPR Newswire2026-09-01Emmanuelle Guégan appointed President Marketing & Services and member of TotalEnergies’ Executive CommitteeBusiness Wire
Documents & Filings
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.